Unknown

Dataset Information

0

Recovery of renal function after long-term dialysis and resolution of cardiomyopathy in a patient with aHUS receiving eculizumab.


ABSTRACT: We present the case of a 18-month-old girl with renal and cardiac manifestations of atypical haemolytic uraemic syndrome (aHUS), and a novel complement factor H mutation. Transient haematological remission was achieved with intensive plasmapheresis, but cardiac function deteriorated and renal function was not restored. Initiation of eculizumab after 6?months of dialysis significantly improved organ function. At 43?months after presentation, haematological values had normalised and cardiac function had improved. Dialysis was discontinued after 10?months (the longest reported time in a patient with aHUS) and the estimated glomerular filtration rate had recovered to 70?mL/min/1.73?m(2). In conclusion, treatment of aHUS with eculizumab, even after long-term dialysis, can significantly improve renal function. Discontinuation of dialysis and resolution of cardiac function has implications on the potential recovery and treatment choice of such patients. Earlier initiation of eculizumab, however, might have prevented the irreversible renal sclerosis and cardiac dysfunction.

SUBMITTER: Emirova K 

PROVIDER: S-EPMC4840264 | biostudies-literature | 2016 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Recovery of renal function after long-term dialysis and resolution of cardiomyopathy in a patient with aHUS receiving eculizumab.

Emirova Khadizha K   Volokhina Elena E   Tolstova Evgenia E   van den Heuvel Bert B  

BMJ case reports 20160215


We present the case of a 18-month-old girl with renal and cardiac manifestations of atypical haemolytic uraemic syndrome (aHUS), and a novel complement factor H mutation. Transient haematological remission was achieved with intensive plasmapheresis, but cardiac function deteriorated and renal function was not restored. Initiation of eculizumab after 6 months of dialysis significantly improved organ function. At 43 months after presentation, haematological values had normalised and cardiac functi  ...[more]

Similar Datasets

| S-EPMC4449039 | biostudies-literature
| S-EPMC8109016 | biostudies-literature
| S-EPMC6056112 | biostudies-literature
| S-EPMC3822313 | biostudies-literature
| S-EPMC8484124 | biostudies-literature
| S-EPMC8591942 | biostudies-literature
| S-EPMC6451155 | biostudies-literature
| S-EPMC10640484 | biostudies-literature
| S-EPMC9784907 | biostudies-literature
| S-EPMC5316393 | biostudies-other